On September 2, a special group of guests came to Big Vision – a couple of cute rabbits. This is the second time they came to Big Vision, as VIP customers, they came specifically for retinal examinations.
Animal experiments are an important part of drug research. Because the eye size, retinal structure and pigment composition of rabbit eyes are similar to those of human eyes, rabbits are widely used as experimental animal models for ophthalmic drug development. Several specialized papers have reported experiments using laser or drug-induced choroidal neovascularization and retinal edema in rabbit eyes for drug evaluation. Most previous animal experiments have used histopathological examination methods, but histopathological examination can be affected by histological changes such as dehydration, shrinkage, and deformation of eye wall tissue during pathological specimen preparation and sectioning. Ophthalmic optical coherence tomography (OCT) allows for the examination of rabbit eye biopsies, as well as the control of treatment effects at different time points of drug administration, and can provide more valuable data information for drug evaluation.
In animal experiments, high demands are placed on the operability of the equipment and image quality. Some OCTs with manual operation take a long time to position and focus the pupil when examining human eyes; because of the differences between rabbit eyes and human eyes, it is often difficult to successfully capture fundus images. If the image quality does not meet the requirements, researchers cannot get valid examination data.
Recently, a research institution in Guangzhou was looking for suitable equipment for rabbit eye retinal examination, and learned about the fully automated artificial intelligence OCT developed by Big Vision, and unexpectedly, Big Vision’s advanced pupil automatic positioning and focusing algorithm also worked in rabbit eye examination.
As a high-tech enterprise focusing on ophthalmic image analysis, Big Vision is more than willing to play a role in the development of innovative ophthalmic drugs. We welcome active cooperation with research institutions that have the same needs, and together contribute to the progress and development of ophthalmic medical care.
Cute rabbit, welcome to Big Vision again!
September 6, 2021
No comments yet.